Modeling the distribution of Schistosoma mansoni and host snails in Uganda using satellite sensor data and Geographical Information Systems

Autor: Anna-Sofie Stensgaard, Jørgensen A, Nb, Kabatereine, Jb, Malone, Tk, Kristensen

Publikováno v: Europe PubMed Central

The potential value of MODIS satellite sensor data on Normalized Difference Vegetation Index (NDVI) and land surface temperatures (LST) for describing the distribution of the Schistosoma mansoni-"Biomphalaria pfeifferi"/Biomphalaria sudanica parasite

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::03fa06af1e60472ea6d5251ccb9a11ee
https://pubmed.ncbi.nlm.nih.gov/16044680

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study.

Autor: Hansen KH; Department of Oncology, Odense University Hospital, Odense, Denmark. holmskov-hansen@hotmail.com., Lyng MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Kodahl AR; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Asmussen JT; Department of Radiology, Odense University Hospital, Odense, Denmark., Arshad A; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark., Petersen H; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark., Krogh L; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Ehmsen S; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Kristensen TK; Department of Pathology, Odense University Hospital, Odense, Denmark.; Clinical Development, Odense University Hospital, Odense, Denmark., Ditzel HJ; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Publikováno v: BMC medical genomics [BMC Med Genomics] 2024 Nov 21; Vol. 17 (1), pp. 274. Date of Electronic Publication: 2024 Nov 21.

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Autor: Knudsen TA; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Stevenson K; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Werner L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Duke W; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Laurore C; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nag A; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Wollison B; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Hansen DL; Department of Hematology, Odense University Hospital, Odense, Denmark., Ellervik C; Department of Data and Innovation Support, Region Zealand, Soroe, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA.; Department of Pathology, Harvard Medical School, Boston, MA., El Fassi D; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., de Stricker K; Department of Pathology, Odense University Hospital, Odense, Denmark., Ocias LF; Statens Serum Institut, Copenhagen, Denmark., Brabrand M; Department of Hematology, Odense University Hospital, Odense, Denmark., Bjerrum OW; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Overgaard UM; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Frederiksen M; Department of Hematology, Hospital of Southern Jutland, Haderslev, Denmark., Kristensen TK; Department of Pathology, Odense University Hospital, Odense, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Mourits-Andersen T; Department of Hematology, Hospital of South West Jutland, Esbjerg, Denmark., Severinsen MT; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Stentoft J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Starklint J; Department of Hematology, Holstebro Hospital, Holstebro, Denmark; and., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Kjaer L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mullally A; Division of Hematology, Brigham and Women's Hospital, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute, Cambridge, MA.

Publikováno v: Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2107-2119.

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).

Autor: Han SY; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Voutsinas J; Clinical Biostatistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Wu Q; Clinical Biostatistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Vestergaard H; Mastocytosis Center and.; Department of Hematology, Odense University Hospital, Odense, Denmark., Ohgami R; Department of Pathology, Stanford University, Stanford, CA., Kluin PM; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kristensen TK; Mastocytosis Center and.; Department of Pathology, Odense University Hospital, Odense, Denmark., Pullarkat S; Department of Pathology, University of California, Los Angeles, CA., Møller MB; Mastocytosis Center and.; Department of Pathology, Odense University Hospital, Odense, Denmark., Schiefer AI; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria., Baughn LB; Division of Hematopathology, Mayo Clinic, Rochester, MN.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Kim Y; Department of Pathology, City of Hope National Medical Center, Duarte, CA., Czuchlewski D; Department of Pathology, University of New Mexico, Albuquerque, NM., Hilberink JR; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Horny HP; Institute of Pathology, Ludwig-Maximilian University, Munich, Germany., George TI; Department of Pathology, University of New Mexico, Albuquerque, NM.; Department of Pathology, University of Utah, Salt Lake City, UT., Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Ku NK; Department of Pathology, University of California, Los Angeles, CA., Arana Yi C; Department of Pathology, University of New Mexico, Albuquerque, NM., Pullarkat V; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Kohlschmidt J; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Salhotra A; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Soma L; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA., Bloomfield CD; Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Chen D; Division of Hematopathology, Mayo Clinic, Rochester, MN., Sperr WR; Division of Hematology and Hemostaseology, Department of Internal Medicine I, and.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Marcucci G; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Cho C; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College; New York, NY., Akin C; Division of Allergy and Clinical Immunology, University of Michigan, Ann Arbor, Michigan, MI., Gotlib J; Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA., Broesby-Olsen S; Mastocytosis Center and.; Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense, Denmark., Larson M; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL., Linden MA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Deeg HJ; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA., Hoermann G; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College; New York, NY., Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Litzow MR; Department of Internal Medicine and.; Division of Hematology, Mayo Clinic, Rochester, MN., Nakamura R; Division of Hematology and HCT, City of Hope National Medical Center, Duarte, CA., Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Borthakur G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX; and., Huls G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Valent P; Division of Hematology and Hemostaseology, Department of Internal Medicine I, and.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL., Yeung CCS; Clinical Reseach Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, WA.

Publikováno v: Blood advances [Blood Adv] 2021 May 25; Vol. 5 (10), pp. 2481-2489.

[Acute appendicitis after colonoscopy].

Autor: Nielsen AB, Kristensen TK, Arsic I, Nielsen MF; nielsenm@post7.tele.dk.

Publikováno v: Ugeskrift for laeger [Ugeskr Laeger] 2020 Dec 21; Vol. 182 (52).